Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins.
about
Identification of a lysosomal peptide transport system induced during dendritic cell developmentPeptide specificity and lipid activation of the lysosomal transport complex ABCB9 (TAPL)Trans-dominant cellular inhibition of DC-SIGN-mediated HIV-1 transmissionEndogenous Antigen Presentation of MHC Class II Epitopes through Non-Autophagic PathwaysExcessive Cytosolic DNA Fragments as a Potential Trigger of Graves' Disease: An Encrypted Message Sent by Animal ModelsMHC class II presentation of gp100 epitopes in melanoma cells requires the function of conventional endosomes and is influenced by melanosomes.Pathways of antigen processing.Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope display.Diminished intracellular invariant chain expression after vaccinia virus infection.Inhibition of glycolipid shedding rescues recognition of a CD1+ T cell lymphoma by natural killer T (NKT) cells.Exosome-driven antigen transfer for MHC class II presentation facilitated by the receptor binding activity of influenza hemagglutininAlternative Ii-independent antigen-processing pathway in leukemic blasts involves TAP-dependent peptide loading of HLA class II complexes.Alternative endogenous protein processing via an autophagy-dependent pathway compensates for Yersinia-mediated inhibition of endosomal major histocompatibility complex class II antigen presentation.In vivo requirement for Atg5 in antigen presentation by dendritic cells.Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes.Genetic basis of remitting sarcoidosis: triumph of the trimolecular complex?Macronutrient deprivation modulates antigen trafficking and immune recognition through HSC70 accessibility.Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathwaysFunctional macroautophagy induction by influenza A virus without a contribution to major histocompatibility complex class II-restricted presentation.Parasite fate and involvement of infected cells in the induction of CD4+ and CD8+ T cell responses to Toxoplasma gondii.EpsinR, a target for pyrenocine B, role in endogenous MHC-II-restricted antigen presentation.Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccineMHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cellsT cell-based therapies for EBV-associated malignancies.Compartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing.The Tumor Antigen NY-ESO-1 Mediates Direct Recognition of Melanoma Cells by CD4+ T Cells after Intercellular Antigen Transfer.Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTLDetermination of the minimum fully protective dose of adenovirus-based DIVA vaccine against peste des petits ruminants virus challenge in East African goats.Proteasomes, TAP, and endoplasmic reticulum-associated aminopeptidase associated with antigen processing control CD4+ Th cell responses by regulating indirect presentation of MHC class II-restricted cytoplasmic antigensLAMP-2C Inhibits MHC Class II Presentation of Cytoplasmic Antigens by Disrupting Chaperone-Mediated AutophagyIdentification of T-cell epitopes for cancer immunotherapy.Cytosol to lysosome transport of intracellular antigens during immune surveillance.B cells induce tolerance by presenting endogenous peptide-IgG on MHC class II molecules via an IFN-gamma-inducible lysosomal thiol reductase-dependent pathwayEpigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy.Autophagy in CD4+ T-cell immunity and tolerance.HSP90alpha and HSP90beta isoforms selectively modulate MHC class II antigen presentation in B cells.Autophagy and its role in MHC-mediated antigen presentation.Impaired antigen presentation in neoplasia: basic mechanisms and implications for acute myeloid leukemia.Beyond the classical: influenza virus and the elucidation of alternative MHC class II-restricted antigen processing pathways.CIITA-regulated plexin-A1 affects T-cell-dendritic cell interactions.
P2860
Q24299256-6938A9BB-F41A-46DC-89A0-2A034591F9DBQ24324713-1EA2B03D-E253-4B77-8B6E-AAB83F87FC6CQ24801408-32DE017E-6480-48C0-BE91-C649CB591A53Q26781304-16D20D58-B368-4687-B98F-7984EC2B2DBAQ28067414-496C8A05-E63A-409B-B863-7DDE69E794DFQ30437794-BC691F8F-FB1A-4E77-A24A-A9A982388F24Q33631854-75DFE7AC-F143-428A-9B6D-F7074FB99E2FQ33719767-738D6380-D8B8-49FD-8D7D-9425AF47821CQ33747640-B3A607D1-B102-47FE-B85D-CF477A39A19CQ34031887-A09898F8-0293-4942-BCE4-6552DD902FBDQ34147894-6E5A1C75-FFD0-413C-9358-0BB3F1648586Q34155000-C30D7CF0-71EB-4D78-A3AA-350415911233Q34309646-4074233F-CAE9-4E94-8DF5-F0899AC7780CQ34376166-AD795DA5-B5AF-4B70-B305-3EC8E35D67D9Q34593324-549D3890-FE68-45F4-8076-F63C3549D974Q34925005-B0C18005-8B4D-409F-AB4B-988717BD755EQ35072364-22B94A0B-36AD-4A3C-9506-27ABD59EE0B3Q35076771-6AED5C34-0E86-4B5D-B9C1-4F1FCF5DB609Q35077602-7E412EC1-C502-4710-8594-EBEC9B770D55Q35145091-469F0B9F-123A-470F-8CCC-5A1B9403938BQ35241354-8C0B1DDC-BB89-44C8-890B-E002588605BEQ35326248-632AFD29-0C4D-4785-922F-356C430E7EBFQ35573814-122F689C-86BA-4379-90ED-3D9C57787B61Q35609768-38E44AB9-1A76-454A-8D72-0764775A3509Q36266489-D503D302-F480-4C89-8700-FF1A8BEABEE5Q36382255-1D15C88D-B992-4D97-846F-5BC533158E37Q36403664-118DE7D4-1E6A-4A62-AEB4-17ADA372A811Q36485614-FE4D572E-91B2-4B7C-A825-9752FDFBE37AQ36509997-65B87FE0-F1B8-41CC-B2E3-E8BCBFD3B1E0Q36655722-474F81D8-A0E8-4124-8E4F-BA2AF4939800Q36870592-D34B5DDC-04E4-4572-A42F-32D2DDCE7302Q36960654-2CE6C1FA-940B-44F7-8EB0-3BB3B9EBA842Q36983280-EE29AE7A-08E9-4415-9BC9-180CC9AB16B7Q37079110-CF14C3FA-E0C9-4DE8-B146-859F114199D8Q37219526-D311B021-BFB8-4B60-9B44-1F1321DE7E15Q37272863-5FD16BEB-1BA4-4842-83CF-7A8B38525FC7Q37315630-DC4F6D91-C366-4BCF-A558-3DD248616FBEQ37773238-EF4C7DCE-D9C8-4070-9A1E-A767581A17D3Q37958695-BF3B3D5D-CC89-4793-9AFF-EDD197DDDD09Q38351580-57E73DBD-2C40-478E-9F70-E79A54BB3DC9
P2860
Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Cytoplasmic processing is a pr ...... ity complex class II proteins.
@ast
Cytoplasmic processing is a pr ...... ity complex class II proteins.
@en
type
label
Cytoplasmic processing is a pr ...... ity complex class II proteins.
@ast
Cytoplasmic processing is a pr ...... ity complex class II proteins.
@en
prefLabel
Cytoplasmic processing is a pr ...... ity complex class II proteins.
@ast
Cytoplasmic processing is a pr ...... ity complex class II proteins.
@en
P2093
P2860
P356
P1476
Cytoplasmic processing is a pr ...... ity complex class II proteins.
@en
P2093
P2860
P304
P356
10.1084/JEM.191.9.1513
P407
P577
2000-05-01T00:00:00Z